A framework for evaluating unexpected reactions in antibody-drug conjugates during clinical development: a case study of a promiscuous payload
Eef H. C. Dirksen, Marijn Buurman, Jeroen Kooistra, Benno Ingelse, Ruud Ubink · 2026
Read A framework for evaluating unexpected reactions in antibody-drug conjugates during clinical development: a case study of a promiscuous payload by Eef H. C. Dirksen, Marijn Buurman, Jeroen Kooistra, Benno Ingelse, Ruud Ubink (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13596894.txt.
Description
Dirksen, Ubink and their co-authors set out a framework for judging surprise reactions in antibody-drug conjugates during drug development. Their work, listed for 2026, uses a real case where a stored product lost much of its killing power.
These drugs join an antibody to a small toxic payload by a linker. Tests found a cross-link had formed inside one product, tying the linker-drug to part of the antibody, and that link wiped out its cell-killing effect. The same link also formed in the body, but its effect on drug levels was small. The authors offer their steps as a general guide for risk checks.
Catalog record
| CREATOR | Eef H. C. Dirksen, Marijn Buurman, Jeroen Kooistra, Benno Ingelse, Ruud Ubink |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |